EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study

Xinliang Liu, Cheng Zhou iD, Wenlong Qiu, Zongqi Li, Fangze Wei, Tixian Xiao, Shiwen Mei, Fei Huang, Fuqiang Zhao, Qian Liu

Cancers · 29.07.2026 · 18 (15) · 2445

DOI: 10.3390/cancers18152445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.07.2026. Verfasst von Xinliang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National High Level Hospital Clinical Research Funding, Cooperation Fund of Cancer Hospital of Chinese Academy of Medical Sciences, Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to determine the optimal temporal threshold for distinguishing “early” from “late” liver metastasis in patients who developed liver metastasis after colorectal cancer (CRC) surgery, and to evaluate whether KRAS and BRAFV600E mutations, along with other clinicopathological factors, are associated with the timing of liver metastasis.

Methods

This retrospective study utilized clinical and pathological data from patients who developed liver metastasis after radical CRC surgery at two centers from 2019 to 2023. X-tile software was used to identify the optimal temporal threshold. Logistic regression analysis was applied to determine if KRAS/BRAFV600E mutations and other potential factors are independently associated with the time to onset of liver metastasis.

Results

X-tile analysis identified 11 months post-surgery as the optimal cutoff for distinguishing early metachronous liver metastasis (EMLM) from late metachronous liver metastasis (LMLM), classifying 114 cases into the EMLM group and 72 into the LMLM group. Comparative analysis indicated statistically significant differences between the two groups in lymphovascular tumor emboli, perineural invasion, and postoperative adjuvant therapy (p < 0.05). Logistic regression analysis revealed that neither KRAS mutation (OR, 1.185; 95% CI: 0.641–2.190; p = 0.587) nor BRAFV600E mutation (OR, 2.836; 95% CI: 0.302–26.642; p = 0.363) was independently associated with the timing of liver metastasis. In contrast, postoperative adjuvant therapy showed a statistical association with a likelihood of LMLM (OR, 0.253; 95% CI: 0.105–0.611; p = 0.002).

Conclusions

This study identified 11 months post-CRC surgery as the optimal cutoff for differentiating EMLM versus LMLM. In this cohort, no statistically significant association was observed between KRAS/BRAFV600E mutations and the timing of liver metastasis, whereas postoperative adjuvant therapy was statistically correlated with the likelihood of LMLM. This stratification may guide personalized surveillance strategies and provide valuable insights for future mechanistic investigations into the temporal heterogeneity of post-surgical liver metastasis. However, the interpretation and generalization of the findings require external validation in prospective cohorts.

Schlagwörter

Stichwörter der Autor:innen

BRAFV600E mutationKRAS mutationassociated factorscolorectal cancercolorectal liver metastasisearly metachronous liver metastasislate metachronous liver metastasis

Autor:innen und Institutionen

  • Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

ORCID-Profile: Cheng Zhou

Förderung

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • National High Level Hospital Clinical Research Funding, Cooperation Fund of Cancer Hospital of Chinese Academy of Medical Sciences
  • Beijing Municipal Natural Science Foundation
  • Beijing Municipal Science and Technology Program

Zitieren

APA

Liu, X., Zhou, C., Qiu, W., Li, Z., Wei, F., Xiao, T., Mei, S., Huang, F., Zhao, F., & Liu, Q. (2026). Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study. Cancers, 18(15), 2445. https://doi.org/10.3390/cancers18152445

Vancouver

Liu X, Zhou C, Qiu W, Li Z, Wei F, Xiao T, et al. Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study. Cancers. 2026;18(15):2445. doi:10.3390/cancers18152445

BibTeX
@article{Liu2026,
  author = {Liu, Xinliang and Zhou, Cheng and Qiu, Wenlong and Li, Zongqi and Wei, Fangze and Xiao, Tixian and Mei, Shiwen and Huang, Fei and Zhao, Fuqiang and Liu, Qian},
  title = {Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2445},
  doi = {10.3390/cancers18152445}
}
Kostenlos starten →